Globalization of Biosimilars

This track discuses about the generic drugs impact on global biosimilar market , Cost and risk management, Adopting innovative mechanisms such as risk-sharing arrangement, European market for biosimilars.

The global market scenario with the launch of first biosimilar in the market forecasts some radical changes. This track will look upon such key concerns which are witnessed by the global pharma market and that are coming up with the subsequent launch of the other biosimilars and biologics. Despite these emerging facilities, biotherapeutic developers are most comfortable off-shoring to established markets—the US and Europe.

 

  • Economic aspect towards biosimilars
  • Biosimilars in global market
  • Investment and returns on biosimilars
  • Cost and risk management
  • Adopting innovative mechanisms such as risksharing arrangement
  • Global P&R models for the biosimilars and generics market

Related Conference of Globalization of Biosimilars

October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
February 28-March 01, 2019

Global Pharmaceutical & Pharma Industry Conference

Osaka, Japan
March 18-19, 2019

13th International Conference on Biosimilars and Biologics

Amsterdam | Netherlands
August 5-6, 2019

13th Asian Biologics and Biosimilars Congress

Melbourne, Australia

Globalization of Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in